Literature DB >> 16010644

Potential benefits of complementary medicine modalities in patients with chronic kidney disease.

Mariana S Markell1.   

Abstract

Use of complementary and alternative medicine (CAM) by the general population is common, and, although potential for harm exists, evidence is accumulating that several modalities, including acupuncture, massage, relaxation response/guided or integrative imagery, meditation, and herbal supplements, have actions that are beneficial for patients with chronic illness. Potential areas in which CAM might benefit patients with kidney disease include prolonging time of progression to kidney failure as well as treatment of concomitant problems, including arthritides, pruritus, cardiovascular risk factors, anxiety, depression, and fatigue, as well as hepatoprotection and treatment of uremic bruising. Although no systematic survey of prevalence of use has been performed in patients with chronic kidney disease and much research remains to be done so that safety and efficacy issues can be resolved, it is likely that many patients are using the services of CAM providers without the knowledge of their nephrologists. Thus, it behooves us to become conversant in these therapies so that we may hold open dialogues with our patients, discouraging potentially harmful treatments, suggesting potentially helpful ones, and monitoring them for effects, both beneficial and harmful.

Entities:  

Mesh:

Year:  2005        PMID: 16010644     DOI: 10.1016/j.ackd.2005.03.004

Source DB:  PubMed          Journal:  Adv Chronic Kidney Dis        ISSN: 1548-5595            Impact factor:   3.620


  13 in total

Review 1.  Targeted treatment of pruritus: a look into the future.

Authors:  H L Tey; G Yosipovitch
Journal:  Br J Dermatol       Date:  2011-05-30       Impact factor: 9.302

2.  Psychosomatic factors in pruritus.

Authors:  Hong Liang Tey; Joanna Wallengren; Gil Yosipovitch
Journal:  Clin Dermatol       Date:  2013 Jan-Feb       Impact factor: 3.541

Review 3.  Assessing and Treating Chronic Pain in Patients with End-Stage Renal Disease.

Authors:  Flaminia Coluzzi
Journal:  Drugs       Date:  2018-09       Impact factor: 9.546

Review 4.  Diabetic nephropathy among Mexican Americans.

Authors:  Subrata Debnath; Farook Thameem; Tahira Alves; Jacqueline Nolen; Hania Al-Shahrouri; Shweta Bansal; Hanna E Abboud; Paolo Fanti
Journal:  Clin Nephrol       Date:  2012-04       Impact factor: 0.975

5.  Use of complementary and alternative medicines in haemodialysis patients: a cross-sectional study from Palestine.

Authors:  Sa'ed H Zyoud; Samah W Al-Jabi; Waleed M Sweileh; Ghada H Tabeeb; Nora A Ayaseh; Mayas N Sawafta; Razan L Khdeir; Diana O Mezyed; Dala N Daraghmeh; Rahmat Awang
Journal:  BMC Complement Altern Med       Date:  2016-07-11       Impact factor: 3.659

6.  Use of complementary and alternative medicine by patients with end-stage renal disease on haemodialysis in Trinidad: A descriptive study.

Authors:  Mandreker Bahall
Journal:  BMC Complement Altern Med       Date:  2017-05-04       Impact factor: 3.659

7.  Chinese Herbal Medicine Improves the Long-Term Survival Rate of Patients With Chronic Kidney Disease in Taiwan: A Nationwide Retrospective Population-Based Cohort Study.

Authors:  Kuo-Chin Huang; Yuan-Chih Su; Mao-Feng Sun; Sheng-Teng Huang
Journal:  Front Pharmacol       Date:  2018-10-01       Impact factor: 5.810

8.  Usage of complementary and alternative medicine among patients with chronic kidney disease on maintenance hemodialysis.

Authors:  Aravapalli S M Arjuna Rao; D Phaneendra; Ch Divya Pavani; P Soundararajan; N Vanitha Rani; P Thennarasu; G Kannan
Journal:  J Pharm Bioallied Sci       Date:  2016 Jan-Mar

9.  Evaluating the effect of garlic extract on serum inflammatory markers of peritoneal dialysis patients: a randomized double-blind clinical trial study.

Authors:  Elham Zare; Amirhesam Alirezaei; Mahmood Bakhtiyari; Asieh Mansouri
Journal:  BMC Nephrol       Date:  2019-01-25       Impact factor: 2.388

10.  Complementary and Alternative Medicine Practice Among Saudi Patients with Chronic Kidney Disease: A Cross-Sectional Study.

Authors:  Layla AlAnizy; Khalid AlMatham; Asmaa Al Basheer; Isamme AlFayyad
Journal:  Int J Nephrol Renovasc Dis       Date:  2020-01-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.